Johnson & Johnson (JNJ) Could Get $5B+ for Diagnostics Unit; Initial Bids Submitted
Tweet Send to a Friend
Johnson & Johnson (NYSE: JNJ) is on watch following reports that it might have received bids for its diagnostics unit.
This article: 150 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 150 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
